Keeping up with corporate filings shouldn't be a full-time job.

Lack of time and motivation to wade through dense documents means missing out on portfolio-boosting opportunities.

Stay informed, invest smarter: AI-powered corporate filing summaries.

Setup Free Alerts → Browse Latest Filings

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

1101

1

BAIYU Holdings, Inc. BAIYU Holdings Reports Mixed Q3 Results, Net Income Recovery Amid Economic Challenges

Via official filing (AI summary) | 10 days ago | 0 comments

1102

1

Orgenesis Inc. Orgenesis Inc. Reports 215% Revenue Growth, Operating Loss in Q3 2024

Via official filing (AI summary) | 10 days ago | 0 comments

1103

1

Peraso Inc. Peraso Inc. Reports 11% Revenue Decline, Net Losses in Q3 2024

Via official filing (AI summary) | 10 days ago | 0 comments

1104

1

Lordstown Motors Corp. Nu Ride Inc. Reports Improved Financials Following Bankruptcy Emergence, Net Income Turnaround

Via official filing (AI summary) | 10 days ago | 0 comments

1105

1

SilverSun Technologies, Inc. QXO, Inc. Reports Significant Financial Developments Following Strategic Changes and Investments

Via official filing (AI summary) | 10 days ago | 0 comments

1106

1

Global Gas Corp Global Gas Corporation Reports Mixed Financial Results, Net Income Recovery in Latest 10-Q Filing

Via official filing (AI summary) | 10 days ago | 0 comments

1107

1

Wilhelmina International, Inc. Wilhelmina International Reports Mixed Q3 Results, Net Income Up 28.6% for Nine Months

Via official filing (AI summary) | 10 days ago | 0 comments

1108

1

INTRUSION INC Intrusion Inc. Reports Mixed Revenue Performance, Improved Net Losses in Q3 2024

Via official filing (AI summary) | 10 days ago | 0 comments

1109

1

Verde Clean Fuels, Inc. Verde Clean Fuels Reports Operating Losses, Strategic Developments in Clean Fuels Technology Initiatives

Via official filing (AI summary) | 10 days ago | 0 comments

1110

1

Instil Bio, Inc. Instil Bio Reports Improved Financials, Reduced Operating Expenses, and Strategic Developments in Latest 10-Q Filing

Via official filing (AI summary) | 10 days ago | 0 comments

1111

1

Lexeo Therapeutics, Inc. Lexo Therapeutics Reports Financial Results, Advances Clinical Programs Amid Ongoing Losses

Via official filing (AI summary) | 10 days ago | 0 comments

1112

1

Marathon Bancorp, Inc. /MD/ Marathon Bancorp Reports 102.9% Increase in Net Income, Net Income of $174,907 in Q3 2024

Via official filing (AI summary) | 10 days ago | 0 comments

1113

1

AFC Gamma, Inc. Advanced Flower Capital Inc. Reports Decline in Revenue and Profitability in Latest Quarter

Via official filing (AI summary) | 10 days ago | 0 comments

1114

1

Acasti Pharma Inc. Grace Therapeutics Reports Financial Results, Focuses on Lead Drug Candidate GTx-104

Via official filing (AI summary) | 10 days ago | 0 comments

1115

1

Clene Inc. Clene Inc. Reports Mixed Financial Results for Q3 and Nine Months Ended September 30, 2024

Via official filing (AI summary) | 10 days ago | 0 comments

1116

1

Liquidia Corp Liquidia Corporation Reports 21% Q3 Revenue Growth, Significant Expenses Increase, and Strategic Developments

Via official filing (AI summary) | 10 days ago | 0 comments

1117

1

Aerkomm Inc. Aerkomm Inc. Reports Significant Revenue Decline, Net Loss in Latest Quarter

Via official filing (AI summary) | 10 days ago | 0 comments

1118

1

Passage BIO, Inc. Passage Bio Reports Improved Financials, Net Loss Reduction, and Strategic Developments in Q3 2024

Via official filing (AI summary) | 10 days ago | 0 comments

1119

1

First Wave BioPharma, Inc. Entero Therapeutics Reports Improved Financials, Shifts Focus After ImmunogenX Acquisition

Via official filing (AI summary) | 10 days ago | 0 comments

1120

1

Venus Concept Inc. Venus Concept Reports Decline in Financial Performance for Q3 and Nine Months of 2024

Via official filing (AI summary) | 10 days ago | 0 comments

1121

1

Fulcrum Therapeutics, Inc. Fulcrum Therapeutics Reports Turnaround in Financial Performance, Net Income of $6.8M for Nine Months Ended September 30, 2024

Via official filing (AI summary) | 10 days ago | 0 comments

1122

1

Wag! Group Co. Wag! Group Reports Significant Revenue Decline and Net Loss in Latest Quarter

Via official filing (AI summary) | 10 days ago | 0 comments

1123

1

LEXICON PHARMACEUTICALS, INC. Lexicon Pharmaceuticals Reports Significant Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 10 days ago | 0 comments

1124

1

Mural Oncology plc Mural Oncology Reports Financial Results, Anticipates Continued Losses Amid Clinical Development Efforts

Via official filing (AI summary) | 10 days ago | 0 comments

1125

1

Unicycive Therapeutics, Inc. Unicycive Therapeutics Reports Improved Liquidity, Reduced Losses, and Advances in Key Drug Candidate

Via official filing (AI summary) | 10 days ago | 0 comments